![ethyl [(1R)-8-ethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetate](https://static.cymitquimica.com/cas-image/31530-ethyl-1r-8-ethyl-1349-tetrahydropyrano-34-b-indol-1-yl-acetate.png)
CAS: 87226-41-3 - ethyl [(1R)-8-ethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetate
Formula:C17H21NO3
InChI:InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)/t17-/m1/s1
InChI key:InChIKey=NNYBQONXHNTVIJ-QGZVFWFLSA-N
SMILES:O=C(O)CC1(OCCC=2C=3C=CC=C(C3NC21)CC)CC
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | (R)-Etodolac REF: 4Z-E-056CAS: 87226-41-3 | - - - | To inquire | Mon 15 Jul 24 |
 | (R)-Etodolac REF: 54-BICR251CAS: 87226-41-3 | - - - | 1,056.00 €~1,362.00 € | Mon 15 Jul 24 |
 | (R)-(-)-Etodolac REF: TR-E933090CAS: 87226-41-3 | - - - | 279.00 €~1,852.00 € | Tue 16 Jul 24 |
 | (R)-(-)-Etodolac REF: 3D-FE23193CAS: 87226-41-3 | Min. 95% | To inquire | Mon 19 Aug 24 |
Ref: 4Z-E-056
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 15 Jul 2024
Ref: 54-BICR251
| 25mg | 1,056.00 € | ||
| 50mg | 1,362.00 € |
Estimated delivery in United States, on Monday 15 Jul 2024
(R)-(-)-Etodolac
Controlled ProductCAS:87226-41-3
Applications The R-enantiomer of Etodolac (E933090). Anti-inflammatory; analgesic. References Boxenbaum, H., et al.: J. Pharmacokin. …
Formula:
C17H21NO3
Color and Shape:
Neat
Molecular weight:
287.354
Ref: TR-E933090
| 5mg | 279.00 € | ||
| 50mg | 1,852.00 € |
Estimated delivery in United States, on Tuesday 16 Jul 2024
(R)-(-)-Etodolac
CAS:87226-41-3
Etodolac is a non-steroidal anti-inflammatory drug (NSAID) that inhibits prostaglandin synthesis. It also has a …
Formula:
C17H21NO3
Purity:
Min. 95%
Molecular weight:
287.35 g/mol
Ref: 3D-FE23193
| 1mg | To inquire | ||
| 2mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Monday 19 Aug 2024
